Angiogenic tissue implant systems and methods

Details Angiogenic tissue implant systems and methods Angiogenic tissue implant systems and methods

A - Human Necessities

61

L

A61L 27/00 (2006.01) A61F 2/02 (2006.01) A61K 9/00 (2006.01) A61L 27/38 (2006.01)

Patent

CA 2132016

2132016 9319701 PCTABS00027 Implant assemblies (10) and methodologies provide immuno-protection for implanted allografts, xenografts, and isografts. The assemblies and methodologies establish an improved boundary between the host and the implanted cells (12). The boundary has a pore size, an ultimate strength, and a metabolic transit value that assures the survival of the cells (12) during the critical ischemic period and afterward. The boundary allows the fabrication and clinical use of implant assemblies and methodologies that can carry enough cells (12) to be of therapeutic value to the host, yet occupy a relatively small, compact area within the host.

Affiliated with

Also associated with

Rating

Angiogenic tissue implant systems and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Angiogenic tissue implant systems and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiogenic tissue implant systems and methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1461539